DJIA 17,949.59 -85.34 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

Geron Corp (NASDAQ: GERN)



company name or ticker

Why Geron Corporation Stock Is Down a Shocking 52% in 2014

The FDA's clinical hold on imetelstat has rocked Geron's shares this year.

Living Longer And Making Money: Life Extending Businesses

Why You Shouldn't Bet Against Geron Corporation (GERN) Stock - Tale of the Tape

Geron: Best Buy In The Market

Geron's (GERN) CEO John Scarlett on Q2 2014 Results - Earnings Call Transcript

Geron's (GERN) CEO John Scarlet on Q2 2014 Results - Earnings Call Transcript

3 Longtime Losers About to See Green?

These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation

Better Buy: Dynavax Technologies Corp. vs. Geron Corp.

Dynavax Technologies Corp. and Geron Corp. have pending catalysts that could cause their shares to double from current levels. Here's a Foolish look at which company offers the better risk-to-reward profile.